巨子 ICON - 財經股票資訊及專家分析
快訊
資訊
    虛擬市場
    搜尋 股票/指數/編號

    快訊

    資訊

    Diffusion Pharmaceuticals

    DFFN
    5.590
    0.130
    2.27%
    最少15分鐘延遲,股票資訊由第三方資訊供應商提供
    ・Diffusion Pharmaceuticals - 延遲價格・最後更新於 26/09 12:00
    最高位
    5.590
    最低位
    5.590
    開市價
    --
    前收市價
    5.720
    成交量(千)
    0.10
    成交額(百萬)
    0.01
    買入
    --
    賣出
    --
    每手股數
    --
    市值(百萬)
    11.40
    市盈率
    --
    息率
    --
    差價
    --
    52週高低
    26.246 - 5.100
    所有資料不保證絕對正確、完整、或實時,僅作為參考使用。投資涉及風險,過往業績並不代表將來表現,作任何投資決定或交易前,閣下應諮詢獨立專業意見。所有內容均不構成投資建議。

    企業資料

    公司名稱
    Diffusion Pharmaceuticals
    證券代碼
    DFFN.US
    所屬板塊
    Biotechnology
    公司業務
    Diffusion Pharmaceuticals Inc is a clinical-stage biotechnology company. It is focused on extending the life expectancy of cancer patients by improving the effectiveness of current standard-of-care treatments, including radiation therapy and chemotherapy. The company's lead product candidate is trans sodium crocetinate (TSC), which is used for the treatment of glioblastoma multiforme (GBM) and metastatic brain cancer. Geographically business activity of the firm functions through the region of the US.
    發行量
    101924581
    公司總部
    300 East Main Street, Suite 201
    公司網址
    https://www.diffusionpharma.com
    公司電話
    +1 434 220-0718
    暫無內容

    關於

    Diffusion Pharmaceuticals(DFFN.US)所屬的行業板塊為Biotechnology。
    Diffusion Pharmaceuticals Inc is a clinical-stage biotechnology company. It is focused on extending the life expectancy of cancer patients by improving the effectiveness of current standard-of-care treatments, including radiation therapy and chemotherapy. The company's lead product candidate is trans sodium crocetinate (TSC), which is used for the treatment of glioblastoma multiforme (GBM) and metastatic brain cancer. Geographically business activity of the firm functions through the region of the US.
    詳細公司背景可參考: https://www.diffusionpharma.com